西方单中心倾向评分匹配比较:肠道型早期胃癌ESD与手术的短期和长期结局
该研究纳入2005—2015年一家西方三级转诊中心诊断为胃中下三分之一肠道型早期胃癌的患者,按操作分为ESD组与胃次全切除术组,并按年龄、性别、ASA评分、肿瘤大小和浸润深度进行倾向评分匹配。匹配后每组42例,围操作期并发症率两组无差异,5年总生存率与无病生存率亦相近;结论认为在西方背景下ESD治疗早期胃癌安全可行。
要点
- 匹配后ESD组与胃次全切除术组围操作期并发症率无显著差异。
- 两组5年总生存率与无病生存率相近,ESD在西方人群中可行。
- ASA3评分是5年总生存的独立负性预测因素。
核心结论
- 在西方三级转诊中心队列中,肠道型早期胃癌行ESD与胃次全切除术的短期和长期结局相当,支持ESD的安全性与可行性。
研究设计与样本
- 回顾性队列研究,纳入2005—2015年胃中下三分之一肠道型早期胃癌患者,按ESD或胃次全切除术分组,并按年龄、性别、ASA评分、肿瘤大小和浸润深度进行倾向评分匹配,匹配后共84例(每组42例),均完成5年随访。
主要发现
- 围操作期并发症率为7.1%,ESD组4.8%对胃次全切除术组9.5%(p=0.3)。
- 5年总生存率ESD组77.7%对胃次全切除术组71.8%(p=0.78)。
- 5年无病生存率ESD组74.9%对胃次全切除术组72%(p=0.7)。
- 多因素分析中ASA3评分是5年总生存的唯一负性预测因素(OR 6.2;95%CI 2.2-16.8;p<0.001)。
- 无病生存的独立危险因素包括ASA3评分(OR 4.4;95%CI 1.7-10.9;p<0.001)和黏膜下浸润(OR 5.1;95%CI 1.2-22.4;p=0.02)。
临床怎么用
- 在西方人群中,对符合适应证的肠道型早期胃癌可考虑ESD作为与胃次全切除术相当的选项。
- 评估患者时应关注ASA评分与黏膜下浸润,因其与更差的5年生存结局相关。
局限性
- 单中心西方三级转诊中心经验,匹配后样本量较小(每组42例),结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the comparable results between ESD and gastrectomy reported in multiple Asiatic studies, limited data are currently present on the long-term efficacy of ESD for EGC in Western countries. The aim of this study was to compare the short- and long-term outcomes of the endoscopic submucosal dissection and surgery for non-diffuse early gastric cancer treatment in a Western cohort of patients. METHODS: All patients with a diagnosis of intestinal type EGC located in the middle and lower third of the stomach from 2005 to 2015 were enrolled in the study. All patients completed a 5-year follow-up. Patients were divided according to the procedure performed (ESD/subtotal gastrectomy). The two groups were matched for age, gender, ASA score, tumor dimension, and grade of infiltration (mucosa/submucosa). RESULTS: After matching, 84 patients (42 per group) were included in the analysis. Peri-procedural morbidity rate was 7.1% and no difference was observed between the two groups (4.8% vs 9.5% for ESD and STG groups, respectively; p = 0.3). Similar results in terms of 5-year OS and DFS were observed for ESD and STG (77.7% vs 71.8% ; p = 0.78 and 74.9% vs 72% ; p = 0.7, respectively). At the multivariate analysis, ASA3 score was recognized as the only negative predictor factor for the 5-year OS (OR 6.2; 95% CI 2.2-16.8; p < 0.001). Regarding the DFS, both ASA3 score (OR 4.4; 95% CI 1.7-10.9; p < 0.001) and submucosal infiltration(OR 5.1; 95% CI 1.2-22.4 ; p = 0.02) were identified as independent risk factors for a worse outcome. CONCLUSIONS: Our results confirm the safety and feasibility ESD for EGC treatment in a Western setting. In addition, this is one of the few reports showing comparable results both in terms of short- and long-term outcomes between ESD and surgery for intestinal type ECG treatment in Western countries.
引用
- Quero G, Fiorillo C, Longo F, et al. Propensity score-matched comparison of short- and long-term outcomes between surgery and endoscopic submucosal dissection (ESD) for intestinal type early gastric cancer (EGC) of the middle and lower third of the stomach: a European tertiary referral center experience. Surg Endosc. 2020. PMID: 32483697. doi:10.1007/s00464-020-07677-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。